<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19509" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chromoblastomycosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kurien</surname>
            <given-names>George</given-names>
          </name>
          <aff>Kerala University of Health Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sugumar</surname>
            <given-names>Kavin</given-names>
          </name>
          <aff>Department of Surgery, University Hospitals, Cleveland, OH</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sathe</surname>
            <given-names>Nishad C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chandran</surname>
            <given-names>Veena</given-names>
          </name>
          <aff>Royal Perth Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Kurien declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kavin Sugumar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishad Sathe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Veena Chandran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19509.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chromoblastomycosis is a chronic granulomatous infection of the skin and subcutaneous tissue caused by dematiaceous fungi endemic to tropical and subtropical areas. These melanized fungi invade cutaneous tissue through an&#x000a0;inoculation site (usually by traumatic skin penetration when exposed to infected soil), resulting in&#x000a0;slow-growing warty plaques and cauliflower-like lesions that may ulcerate. The diagnosis of chromoblastomycosis is usually made by the histopathologic identification of&#x000a0;clusters of thick-walled cells in&#x000a0;cutaneous tissue&#x000a0;(called medlar bodies, muriform bodies, or sclerotic bodies).</p>
        <p>A neglected tropical disease, chromoblastomycosis can have serious complications (eg, disabling cutaneous fibrosis, secondary infection) that may be irreversible. Recognizing and diagnosing chromoblastomycosis can be challenging, and many&#x000a0;infectious and noninfectious etiologies must be excluded. Because chromoblastomycosis is a chronic, indolent condition, treatment is challenging and can include surgical excision for mild cases to long-term oral antifungal medications for moderate-to-severe cases. However,&#x000a0;the treatment course is long and may be refractory to treatment, requiring other therapies. Even after treatment is initiated, long-term monitoring is essential to ensure the best patient outcomes and prevent recurrence.&#x000a0;This activity describes&#x000a0;the epidemiology, microbiology, pathogenesis, clinical presentation, diagnosis, and management of chromoblastomycosis,&#x000a0;providing healthcare professionals with the knowledge and tools&#x000a0;to improve patient care for this complex condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical features of chromoblastomycosis, recognizing its varied presentations from pink macules to warty plaques and nodules.</p></list-item><list-item><p>Differentiate the myriad&#x000a0;microbiological characteristics of different fungal strains, understanding their implications for disease severity and treatment.</p></list-item><list-item><p>Identify key&#x000a0;clinical findings, assess laboratory findings, and review objective information to diagnose chromoblastomycosis.</p></list-item><list-item><p>Collaborate with the interprofessional team to educate, treat, and monitor patients with&#x000a0;chromoblastomycosis&#x000a0;to improve patient outcomes and prevent complications.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19509&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19509">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19509.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chromoblastomycosis is a chronic granulomatous infection of the skin and subcutaneous tissue caused by several different dematiaceous fungi (ie, fungi containing pigment in the cell wall, whether melanin or melanin-like).<xref ref-type="bibr" rid="article-19509.r1">[1]</xref><xref ref-type="bibr" rid="article-19509.r2">[2]</xref>&#x000a0;The indolent infection begins with the cutaneous inoculation of fungi, usually through some portion of the fungal cell capable of reproduction or propagation (eg, conidia, mycelia), into exposed skin,&#x000a0;typically due to trauma.<xref ref-type="bibr" rid="article-19509.r3">[3]</xref><xref ref-type="bibr" rid="article-19509.r4">[4]</xref>&#x000a0;The infection has wide morphologic variability but typically begins as a pink-to-red macule or papule and evolves in later stages to a verrucous, hyperkeratotic plaque, tumor, or nodule; ultimately, the slow-growing, warty (eg, cauliflower-like) lesions may ulcerate.<xref ref-type="bibr" rid="article-19509.r2">[2]</xref><xref ref-type="bibr" rid="article-19509.r5">[5]</xref>&#x000a0;</p>
        <p>The disease is most common in tropical and subtropical areas, where it is endemic and a neglected tropical disease; as such, it should be most strongly considered in patients who have recently traveled to or originated from these areas.<xref ref-type="bibr" rid="article-19509.r6">[6]</xref>&#x000a0;Diagnosis of chromoblastomycosis&#x000a0;requires the identification of multicellular clusters of&#x000a0;pigmented fungal cells, which produce a characteristic finding called&#x000a0;sclerotic bodies (ie, muriform bodies, copper pennies, medlar bodies) on a potassium hydroxide stain or&#x000a0;with histopathologic analysis of a skin biopsy.<xref ref-type="bibr" rid="article-19509.r4">[4]</xref>&#x000a0;Although other differential diagnoses may include infectious and noninfectious verrucous lesions, the treatment of chromoblastomycosis includes surgical removal for mild disease and&#x000a0;antifungal therapy&#x000a0;for moderate-to-severe disease.<xref ref-type="bibr" rid="article-19509.r7">[7]</xref>&#x000a0;If left untreated, chromoblastomycosis complications can include debilitating tissue fibrosis, squamous cell carcinoma in the site of prior infection, lymphedema, or secondary bacterial infection.<xref ref-type="bibr" rid="article-19509.r8">[8]</xref><xref ref-type="bibr" rid="article-19509.r9">[9]</xref></p>
      </sec>
      <sec id="article-19509.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Many melanized fungi can cause chromoblastomycosis, but the main causes are usually from 2 genera: Fonsecaea spp (especially <italic toggle="yes">F pedrosoi</italic>) and Cladophialophora spp (especially <italic toggle="yes">C carrionii</italic>).<xref ref-type="bibr" rid="article-19509.r10">[10]</xref><xref ref-type="bibr" rid="article-19509.r11">[11]</xref>&#x000a0;Demiataceous fungi (ie, phaeoid, black fungi, pigmented) pathogenic to humans include those nonopportunistic organisms that cause chromoblastomycosis and the opportunistic pathogens that cause pheohyphomycosis, the latter of which&#x000a0;is more likely associated with internal organ involvement.<xref ref-type="bibr" rid="article-19509.r12">[12]</xref>&#x000a0;Important species for chromoblastomycosis include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Fonsecaea spp:</bold>
<italic toggle="yes">F pedrosoi</italic>, <italic toggle="yes">F monophora</italic>, <italic toggle="yes">F nubica</italic>, <italic toggle="yes">F pugnacious</italic>, <italic toggle="yes">F brasiliensis</italic>, <italic toggle="yes">F erecta</italic>)</p>
          </list-item>
          <list-item>
            <p><bold>Cladophialophora spp:</bold>&#x000a0;<italic toggle="yes">C carrionii</italic>,&#x000a0;<italic toggle="yes">C yegresii</italic></p>
          </list-item>
          <list-item>
            <p><bold>Exophiala spp:</bold>&#x000a0;<italic toggle="yes">E dermatitidis</italic> (formerly <italic toggle="yes">Wangiella dermatitidis</italic>),&#x000a0;<italic toggle="yes">E spinifera</italic>,&#x000a0;<italic toggle="yes">E jeanselmei</italic>,&#x000a0;<italic toggle="yes">E alcalophila</italic></p>
          </list-item>
          <list-item>
            <p><bold>Phialophora spp:</bold>
<italic toggle="yes">P&#x000a0;verrucosa</italic>,&#x000a0;<italic toggle="yes"><italic toggle="yes">P americana</italic></italic>,<italic toggle="yes">&#x000a0;<italic toggle="yes">P</italic>&#x000a0;<italic toggle="yes">chinensis</italic></italic>,<italic toggle="yes">
<italic toggle="yes">P macrospora</italic></italic></p>
          </list-item>
          <list-item>
            <p>
<bold>Rhinocladiella spp:&#x000a0;</bold>
<italic toggle="yes">R&#x000a0;<italic toggle="yes">similis, R&#x000a0;<italic toggle="yes">mackenziei, R aquaspersa&#x000a0;</italic></italic></italic>
<xref ref-type="bibr" rid="article-19509.r10">[10]</xref>
<xref ref-type="bibr" rid="article-19509.r13">[13]</xref>
<xref ref-type="bibr" rid="article-19509.r14">[14]</xref>
<xref ref-type="bibr" rid="article-19509.r15">[15]</xref>
<xref ref-type="bibr" rid="article-19509.r16">[16]</xref>
</p>
          </list-item>
        </list>
        <p>These etiologic&#x000a0;organisms exist in cutaneous tissue in various yeast-like forms and reproduce through asexual reproduction, though at least one species has been shown to reproduce through a cleistothecium-like structure.<xref ref-type="bibr" rid="article-19509.r13">[13]</xref><xref ref-type="bibr" rid="article-19509.r17">[17]</xref>&#x000a0;The saprophytic fungi have been isolated from wood, soil, and other plant material in many rural communities, thus implicating their method of entry into the host through trauma and after exposure to plant material.<xref ref-type="bibr" rid="article-19509.r7">[7]</xref><xref ref-type="bibr" rid="article-19509.r18">[18]</xref><xref ref-type="bibr" rid="article-19509.r7">[7]</xref></p>
      </sec>
      <sec id="article-19509.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Chromoblastomycosis is a disease in the humid, semiarid climates of the tropical and subtropical world.<xref ref-type="bibr" rid="article-19509.r19">[19]</xref>&#x000a0;In&#x000a0;1 review of over 2081 patients from South America and the Caribbean,&#x000a0;80.3% were male, and the mean age was 56.1 years.<xref ref-type="bibr" rid="article-19509.r20">[20]</xref>&#x000a0;Disease duration was 10.8 years, with lesions mostly on the lower limbs (60%), and the most common presenting symptoms were itching and pain;&#x000a0;the most common forms of the lesion at presentation were verrucous (46.4%) or tumorous (21.7%).<xref ref-type="bibr" rid="article-19509.r20">[20]</xref>&#x000a0;The most frequent comorbidity in patients with chromoblastomycosis was postkidney transplantation, though leprosy was a common concomitant infection.<xref ref-type="bibr" rid="article-19509.r20">[20]</xref>&#x000a0;Chromoblastomycosis&#x000a0;leads to significant disability in agricultural workers in rural areas, particularly as the disease is spread via direct inoculation into the skin from soil or other plant material. However, adult male agricultural workers are most likely to be diagnosed with chromoblastomycosis; the condition has also been reported in children.<xref ref-type="bibr" rid="article-19509.r20">[20]</xref><xref ref-type="bibr" rid="article-19509.r21">[21]</xref></p>
        <p>The incidence of chromoblastomycosis is difficult to determine since few studies describe its distribution; however, it is a neglected tropical disease more likely to be found in tropical climates and less likely in areas like the United States.<xref ref-type="bibr" rid="article-19509.r22">[22]</xref>&#x000a0;Even in India, chromoblastomycosis represents one of the rare fungal infections seen in 1 study in the population.<xref ref-type="bibr" rid="article-19509.r22">[22]</xref>&#x000a0;Although underestimated&#x000a0;because it is not classified as a notifiable disease to public authorities in many nations, it&#x000a0;is reported to be most common in&#x000a0;3 different continents (South America, Africa, and Asia), with higher reported rates in&#x000a0;Costa Rica, Dominican Republic, Venezuela, French Guyana, Comoros, Madagascar, and Gabon, among others.<xref ref-type="bibr" rid="article-19509.r23">[23]</xref></p>
      </sec>
      <sec id="article-19509.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Chromoblastomycosis follows a similar pattern explaining its pathophysiology; namely, after traumatic inoculation from the environment leading to a chronic cutaneous granulomatous and fibrotic reaction, multiple microabscesses with tissue proliferation develop, leading to a&#x000a0;T-helper cell type 2 (Th2) immune reaction and the embedding of sclerotic bodies in infected tissue and a polymorphous clinical appearance.<xref ref-type="bibr" rid="article-19509.r24">[24]</xref>&#x000a0;After cutaneous inoculation, purportedly following trauma, a dematiaceous fungal species enters the skin and rarely disseminates further.<xref ref-type="bibr" rid="article-19509.r4">[4]</xref>&#x000a0;</p>
        <p>Several days after traumatic implantation, the pigmented fungi differentiate into muriform cells (ie, sclerotic bodies) within phagocytic cells, which explain the fungal globe-shaped, multiseptate morphology.<xref ref-type="bibr" rid="article-19509.r25">[25]</xref><xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;The sclerotic bodies&#x02014;brown septate cells that resemble copper pennies&#x02014;are extruded transepidermally, ultimately appearing as black dots clinically, a characteristic clinicopathologic correlate on physical examination.<xref ref-type="bibr" rid="article-19509.r27">[27]</xref>&#x000a0;During phagocytosis, toll-like receptor dysfunction has been implicated in the host cell's ability to mount an appropriate eradication response, resulting in a granulomatous reaction.<xref ref-type="bibr" rid="article-19509.r28">[28]</xref>&#x000a0;</p>
        <p>Few virulence factors are known in the pathogenesis of chromoblastomycosis, but&#x000a0;many elements of organisms that cause chromoblastomycosis have been implicated.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Melanin:</bold> The presence of melanin has been implicated as a protective mechanism in chromoblastomycosis. Melanin is thought to have unpaired electrons to protect fungal elements from reactive oxygen species produced by macrophages and neutrophils.<xref ref-type="bibr" rid="article-19509.r29">[29]</xref><xref ref-type="bibr" rid="article-19509.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Cell adhesion, invasion, and survival antigens:</bold> Some species that cause chromoblastomycosis have been found to contain specific elements to aid in cell adhesion.<xref ref-type="bibr" rid="article-19509.r31">[31]</xref>&#x000a0;One study showed that peptide-breaking enzymes of <italic toggle="yes">Fonsecaea spp</italic> aid in disseminating and invading fungal elements throughout the cutaneous tissue.<xref ref-type="bibr" rid="article-19509.r32">[32]</xref>&#x000a0;Other species have been shown to have active phospholipase, allowing easy invasion by&#x000a0;lipolysis of the cell membrane and the conversion of&#x000a0;arachidonate to prostaglandins (eg, prostaglandin E<sub>2</sub>), which helps downregulate macrophages, allowing microbial survival.<xref ref-type="bibr" rid="article-19509.r33">[33]</xref><xref ref-type="bibr" rid="article-19509.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Muriform cell architecture:&#x000a0;</bold>Muriform cells have thicker polyhedral cell walls than the thinner ones of hyphae, which may improve the organism's ability to diminish&#x000a0;host response, resulting in fibrous tissue formation; this may be implicated in the chronicity of infection since the fungi can be dormant and proliferate with immune evasion.<xref ref-type="bibr" rid="article-19509.r35">[35]</xref><xref ref-type="bibr" rid="article-19509.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>The immune response also plays an important role in propagating chromoblastomycosis infection. Complement proteins involved in opsonization can be activated by&#x000a0;some <italic toggle="yes">Fonsacaea spp</italic>, resulting in chemoattract proteins (eg, C5a) increasing the local inflammatory response.<xref ref-type="bibr" rid="article-19509.r37">[37]</xref>&#x000a0;For unclear reasons, neutrophils have specificity in their toll-like receptor types to eliminate conidia or hyphae forms of fungi, suggesting specificity among fungal elements and the immune system for fungal elimination.<xref ref-type="bibr" rid="article-19509.r38">[38]</xref>&#x000a0;However, both neutrophils and macrophages have limited ability to kill intracellular fungi, even with an oxidative response, likely related to melanin produced by the fungi.<xref ref-type="bibr" rid="article-19509.r39">[39]</xref><xref ref-type="bibr" rid="article-19509.r30">[30]</xref>&#x000a0;</p>
        <p>Organisms causing chromoblastomycosis have been shown to have resistance to microbicidal molecules,&#x000a0;impacting the effects of major histocompatibility complex class II, CD80, interleukin-12, and T-helper cell type 1 (Th1) responses.<xref ref-type="bibr" rid="article-19509.r40">[40]</xref><xref ref-type="bibr" rid="article-19509.r41">[41]</xref>&#x000a0;Other studies have shown the effect of chromoblastomycosis organisms on interleukin-17, interleukin-10, and Langerhans cells, promoting chronic infection.<xref ref-type="bibr" rid="article-19509.r42">[42]</xref><xref ref-type="bibr" rid="article-19509.r43">[43]</xref><xref ref-type="bibr" rid="article-19509.r44">[44]</xref>&#x000a0;Meanwhile,&#x000a0;the humoral immune response is poorly understood, and immunoglobulins are not yet known to be involved to a great extent. However, some immunodeficiency syndromes (eg, CARD9 mutations)&#x000a0;and&#x000a0;genetic associations (eg, HLA-A29 or HLA-B*4802 deletion) have been associated with developing chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r45">[45]</xref><xref ref-type="bibr" rid="article-19509.r46">[46]</xref><xref ref-type="bibr" rid="article-19509.r45">[45]</xref><xref ref-type="bibr" rid="article-19509.r47">[47]</xref></p>
      </sec>
      <sec id="article-19509.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Once a skin biopsy is performed for both histopathologic&#x000a0;analysis and culture, a microscopic examination will reveal the findings below.<xref ref-type="bibr" rid="article-19509.r24">[24]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Pseudoepitheliomatous hyperplasia of the epidermis</p>
          </list-item>
          <list-item>
            <p>Irregular acanthosis and hyperkeratosis alternating with atrophy</p>
          </list-item>
          <list-item>
            <p>Neutrophilic microabscesses with muriform cells (ie, polyhedral, chestnut-like cells measuring 5-12&#x000a0;&#x003bc;m with&#x000a0;longitudinal septa resembling a brick wall)</p>
          </list-item>
          <list-item>
            <p>Dermal granulomas with epithelioid cells</p>
          </list-item>
          <list-item>
            <p>Increased&#x000a0;number of dermal capillaries</p>
          </list-item>
          <list-item>
            <p>Variable dermal fibrosis associated with mononuclear cells (eg, histiocytes,&#x000a0;plasma cells, lymphocytes)</p>
          </list-item>
        </list>
        <p>However, the most pertinent finding is the presence of sclerotic bodies (ie, medlar bodies, muriform cells, copper pennies) in the dermis (see <bold>Image<italic toggle="yes">.</italic></bold>&#x000a0;Chromomycosis of Skin).<xref ref-type="bibr" rid="article-19509.r48">[48]</xref><xref ref-type="bibr" rid="article-19509.r49">[49]</xref> The tissue between the bodies may show variable levels of fibrosis, depending on the extent and duration of the disease. When ulceration has occurred, there may be a secondary bacterial infection.<xref ref-type="bibr" rid="article-19509.r27">[27]</xref></p>
      </sec>
      <sec id="article-19509.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Following trauma to the skin, usually in an outdoor environment with exposure to soil or plant material, fungi proliferate in the cutaneous tissue.<xref ref-type="bibr" rid="article-19509.r50">[50]</xref>&#x000a0;The evolution of chromoblastomycosis usually starts with a small, pink-to-red macule or papule and can progress to myriad variable morphologic varieties, which depend on the virulence, location, and advancement of the disease;&#x000a0;some common morphologies are listed below.<xref ref-type="bibr" rid="article-19509.r5">[5]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Verrucous papule</p>
          </list-item>
          <list-item>
            <p>Nodules</p>
          </list-item>
          <list-item>
            <p>Scaly plaque</p>
          </list-item>
          <list-item>
            <p>Exophytic or ulcerative tumor (ie, cauliflower-like mass)</p>
          </list-item>
          <list-item>
            <p>Cicatricial plaques</p>
          </list-item>
        </list>
        <p>Typically, most lesions are on the lower extremities (see <bold>Image</bold>. Chromoblastomycosis), and nearly all patients with the disease have had exposure to hot, tropical environments, with the disease progressing in an indolent course, even lasting many weeks prior to presentation.<xref ref-type="bibr" rid="article-19509.r5">[5]</xref> For this reason, after appreciation of the physical findings,&#x000a0;the skin examination&#x000a0;should focus on the extent of the disease, the presence of satellite lesions, or the involvement of deeper organs, which is rare and may instead represent a diagnosis of pheohyphomycosis.<xref ref-type="bibr" rid="article-19509.r51">[51]</xref><xref ref-type="bibr" rid="article-19509.r52">[52]</xref>&#x000a0;Lymphatic spread should be evaluated near the existing lesion or lesions.<xref ref-type="bibr" rid="article-19509.r53">[53]</xref></p>
        <p>Once the physical examination shows characteristic findings that could&#x000a0;indicate chromoblastomycosis, history-taking should emphasize questions intended to rule out other&#x000a0;differential diagnoses. Pruritus is a dominant complaint among patients with chromoblastomycosis, with pain at a later time; however, these findings may&#x000a0;present late in the clinical course of the disease,&#x000a0;particularly in trauma-prone locations.<xref ref-type="bibr" rid="article-19509.r54">[54]</xref>&#x000a0;Patients should be asked&#x000a0;about:</p>
        <list list-type="bullet">
          <list-item>
            <p>Recent travel to endemic tropical or subtropical areas</p>
          </list-item>
          <list-item>
            <p>History of prior surgeries or skin changes in the location (eg, squamous cell carcinoma, keloid)</p>
          </list-item>
          <list-item>
            <p>Exposure of skin to trauma or injury previously (eg, gardening)</p>
          </list-item>
          <list-item>
            <p>Outdoor recreation (eg, hiking, camping)</p>
          </list-item>
          <list-item>
            <p>Occupation (eg, farmer, agricultural worker, outdoor occupations)</p>
          </list-item>
          <list-item>
            <p>Exposure of skin to the environment (eg, walking barefoot, exposure to volcanic soil)</p>
          </list-item>
          <list-item>
            <p>History of malignancy (eg, mycosis fungoides)</p>
          </list-item>
          <list-item>
            <p>History of other infections (eg, bacterial, fungal, protozoan, viral)</p>
          </list-item>
          <list-item>
            <p>History of inflammatory diseases that can present with disfiguring skin lesions (eg, lupus, sarcoidosis)</p>
          </list-item>
          <list-item>
            <p>Family history of fungal infections</p>
          </list-item>
          <list-item>
            <p>Other issues relevant to the history or course of chromoblastomycosis&#x000a0;<xref ref-type="bibr" rid="article-19509.r55">[55]</xref><xref ref-type="bibr" rid="article-19509.r56">[56]</xref><xref ref-type="bibr" rid="article-19509.r57">[57]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>The absence of these historical findings should not exclude chromoblastomycosis since patients may not remember the lesions.</p>
      </sec>
      <sec id="article-19509.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of chromoblastomycosis should be suspected in patients who have indolent courses of verrucous papules, nodules, or plaques who are from or have recently traveled to endemic tropical or subtropical areas; however, it has&#x000a0;also been found&#x000a0;in nonendemic areas.<xref ref-type="bibr" rid="article-19509.r50">[50]</xref><xref ref-type="bibr" rid="article-19509.r58">[58]</xref><xref ref-type="bibr" rid="article-19509.r50">[50]</xref>&#x000a0;Dermoscopy may be used to identify black dots on the lesion, resembling "cayenne pepper" spots, which are associated with the transdermal extrusion of sclerotic bodies.<xref ref-type="bibr" rid="article-19509.r59">[59]</xref>&#x000a0;Scraping the lesion&#x000a0;and applying a potassium hydroxide stain on the glass slide for viewing under a microscope can reveal the presence of copper pennies, the clusters of fungal cells.<xref ref-type="bibr" rid="article-19509.r2">[2]</xref>.</p>
        <p>However,&#x000a0;performing a skin biopsy is most prudent to observe the granulomatous reaction with medlar bodies, the thick-walled pigmented copper bodies in the dermis; either 1 biopsy should be divided for histopathology and culture each, or 2 punch biopsies should be performed.<xref ref-type="bibr" rid="article-19509.r60">[60]</xref>&#x000a0;A calcifluor white stain may be used if the fungal elements are challenging to identify since the fluorescent stain binds fungal cell walls when exposed to ultraviolet light.<xref ref-type="bibr" rid="article-19509.r24">[24]</xref><xref ref-type="bibr" rid="article-19509.r61">[61]</xref><xref ref-type="bibr" rid="article-19509.r62">[62]</xref><xref ref-type="bibr" rid="article-19509.r24">[24]</xref>&#x000a0;Fungal cultures may be used to identify the genus, in which case an antibiotic may&#x000a0;be needed to inhibit bacterial growth, but further molecular testing is needed to identify the species causing chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r63">[63]</xref>&#x000a0;Serologic by immunosorbent assay (eg, enzyme-linked immunosorbent assay [ELISA]) is not commercially available but has been used in research studies.<xref ref-type="bibr" rid="article-19509.r64">[64]</xref><xref ref-type="bibr" rid="article-19509.r65">[65]</xref><xref ref-type="bibr" rid="article-19509.r66">[66]</xref></p>
      </sec>
      <sec id="article-19509.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Chromoblastomycosis treatment depends on the severity and extent of the disease, including the size of lesions, number of lesions,&#x000a0;presence of complications, and prior response to treatment.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;There are few randomized clinical trials to evaluate treatment success. Generally, mild disease&#x000a0;is more amenable to surgical excision,&#x000a0;whereas moderate-to-severe disease&#x000a0;is best addressed with antifungal therapy.<xref ref-type="bibr" rid="article-19509.r67">[67]</xref><xref ref-type="bibr" rid="article-19509.r58">[58]</xref>&#x000a0;Disease severity is classified as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Mild:</bold> Scales or nodules up to 5 cm in diameter</p>
          </list-item>
          <list-item>
            <p><bold>Moderate:</bold> Single or multiple lesions in verrucous, tumoral, or plaque forms on 1 or 2 adjacent body areas up to 15 cm in diameter</p>
          </list-item>
          <list-item>
            <p><bold>Severe:</bold> Single or multiple lesions in extensive areas beyond moderate&#x000a0;<xref ref-type="bibr" rid="article-19509.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Mild Disease </bold>
</p>
        <p>Mild disease is most appropriately treated with procedural intervention, usually surgical excision with&#x000a0;5-mm margins of healthy tissue, to prevent fungal spread through lymphatic channels.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;Mohs micrographic surgery&#x000a0;or skin grafting can be considered on a case-by-case basis.<xref ref-type="bibr" rid="article-19509.r68">[68]</xref>&#x000a0;Other procedural interventions,&#x000a0;which may be used with or without&#x000a0;oral medications,&#x000a0;have included:</p>
        <list list-type="bullet">
          <list-item>
            <p>Photodynamic therapy</p>
          </list-item>
          <list-item>
            <p>Long-pulsed 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser</p>
          </list-item>
          <list-item>
            <p>Carbon dioxide&#x000a0;fractional&#x000a0;laser</p>
          </list-item>
          <list-item>
            <p>Heat therapy (beyond 46 &#x000b0;C for fungicidal activity)</p>
          </list-item>
          <list-item>
            <p>Cryosurgery.<xref ref-type="bibr" rid="article-19509.r69">[69]</xref><xref ref-type="bibr" rid="article-19509.r70">[70]</xref><xref ref-type="bibr" rid="article-19509.r71">[71]</xref><xref ref-type="bibr" rid="article-19509.r72">[72]</xref><xref ref-type="bibr" rid="article-19509.r73">[73]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Moderate-to-Severe Disease</bold>
</p>
        <p>For moderate-to-severe disease, antifungal drugs should be initiated. The primary recommended treatments are terbinafine and itraconazole, administered on dual oral therapy at 200 to 400 mg/day and 250 to 500 mg/day, respectively.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Itraconazole:</bold>&#x000a0;An azole&#x000a0;drug that&#x000a0;inhibits&#x000a0;fungal 14-&#x003b1; demethylase, treatment with&#x000a0;100 to 200 mg&#x000a0;has been used as monotherapy for 12 to 24 months with varying success.<xref ref-type="bibr" rid="article-19509.r74">[74]</xref>&#x000a0;Another study showed that 200 to 400 mg of itraconazole needed to be used for&#x000a0;up to 30.5 months for the clinical cure of <italic toggle="yes">F pedrosoi</italic>.<xref ref-type="bibr" rid="article-19509.r75">[75]</xref>&#x000a0;However, monotherapy is sometimes avoided for improved efficacy, and instead, terbinafine or 5-fluorocytosine (50-150 mg/kg/day)&#x000a0;has been used in conjunction with itraconazole at 100 to 400 mg/kg/day for chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r76">[76]</xref><xref ref-type="bibr" rid="article-19509.r77">[77]</xref>&#x000a0;Pulsed itraconazole at 200 mg daily for 7 days monthly has also been used successfully in patients with chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r78">[78]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Amphotericin B:</bold> Amphotericin B&#x000a0;was shown to be effective when administered locally in chromoblastomycosis lesions; however, the dose may be too high and&#x000a0;cause significant adverse effects,&#x000a0;including pain, hemolysis, fibrosis, and gangrene.<xref ref-type="bibr" rid="article-19509.r79">[79]</xref><xref ref-type="bibr" rid="article-19509.r80">[80]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Terbinafine:</bold> Terbinafine is an allylamine that inhibits squalene epoxidase; it was previously used at 500 mg/kg/day for 6 to 12 months for monotherapy of&#x000a0;chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r81">[81]</xref>&#x000a0;Terbinafine is not successful as monotherapy in other studies, but dual&#x000a0;therapy with terbinafine and&#x000a0;an azole antifungal (eg, itraconazole, voriconazole)&#x000a0;is thought to be synergistic.<xref ref-type="bibr" rid="article-19509.r82">[82]</xref><xref ref-type="bibr" rid="article-19509.r83">[83]</xref><xref ref-type="bibr" rid="article-19509.r84">[84]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Posaconazole and voriconazole:</bold> Both posaconazole and voriconazole have been used for chromoblastomycosis at 800 mg (as 2 or 4 doses) or 400 mg (as 2 doses), respectively, but these are usually limited to refractory cases or cases in which cost or other medications are an issue.<xref ref-type="bibr" rid="article-19509.r85">[85]</xref><xref ref-type="bibr" rid="article-19509.r86">[86]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Imiquimod:</bold> Imiquimod is a toll-like receptor 7 agonist found to significantly improve the lesions of chromoblastomycosis when used with itraconazole with or without terbinafine.<xref ref-type="bibr" rid="article-19509.r87">[87]</xref><xref ref-type="bibr" rid="article-19509.r88">[88]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Glucan:</bold> Glucan is a pathogen-associated molecular pattern that was found to improve the treatment of chromoblastomycosis when used at 5 mg/week with itraconazole at 400 mg/day.<xref ref-type="bibr" rid="article-19509.r89">[89]</xref><xref ref-type="bibr" rid="article-19509.r90">[90]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Retinoids:</bold> Synthetic retinoids like acitretin have been used in combination with other medications (eg, imiquimod, itraconazole) for chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r91">[91]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Melanin Inhibitors:</bold> Molecules like tricyclazole, which inhibits melanin, have been thought to help with fungicidal activity in chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r92">[92]</xref>&#x000a0;The use of melanin inhibitors in conjunction with antifungal therapy might be useful to reduce fungal defenses for better antifungal penetration.<xref ref-type="bibr" rid="article-19509.r93">[93]</xref></p>
          </list-item>
        </list>
        <p>Other medications of interest for fungicidal properties include HIV peptidase inhibitors and ajoene (garlic extract that inhibits phosphatidylcholine biosynthesis).<xref ref-type="bibr" rid="article-19509.r94">[94]</xref>&#x000a0;The presence of adverse effects (eg, hepatotoxicity in terbinafine) may change drug choice, and complications of the disease (eg, fibrosis) can affect the availability of the medication in cutaneous tissue. For example, although liver function monitoring may be required for terbinafine, it has&#x000a0;fewer drug-drug interactions compared with itraconazole, which may warrant its selection.</p>
        <p>Because fungi can spread to adjacent healthy skin, monitoring after complete&#x000a0;clinical resolution for several months without symptoms is necessary and can include regular skin biopsies with culture and fungal assessments. Regular follow-up should be performed to ensure complete treatment, barring&#x000a0;expected atrophic scarring.</p>
      </sec>
      <sec id="article-19509.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of chromoblastomycosis should include infectious and noninfectious causes that can appear clinically similar. Infectious causes that appear similar and should be considered include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Fungal:</bold> Lobomycosis,&#x000a0;Pheohyphomycosis, Eumycetoma, Blastomycosis, Coccidioidomycosis, Sporotrichosis, Majocchi granuloma, Paracoccidiomycosis)</p>
          </list-item>
          <list-item>
            <p><bold>Bacterial:</bold> Tuberculosis, Actinomycetoma, Botryomycosis, Syphilis, Yaws,&#x000a0;Nontuberculous mycobacterial infection</p>
          </list-item>
          <list-item>
            <p><bold>Viral:</bold> Verruca vulgaris, Papilloma</p>
          </list-item>
          <list-item>
            <p><bold>Protozoan:</bold> Leishmaniasis, Rhinosporidiosis</p>
          </list-item>
          <list-item>
            <p><bold>Helminth:</bold> Filariasis</p>
          </list-item>
          <list-item>
            <p><bold>Alga:</bold> Protothecosis&#x000a0;<xref ref-type="bibr" rid="article-19509.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>Noninfectious causes should also be considered due to similar clinical appearance or due to complications of chromoblastomycosis, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Melanoma</p>
          </list-item>
          <list-item>
            <p>Squamous cell carcinoma (eg, keratoacanthoma)</p>
          </list-item>
          <list-item>
            <p>Keloid</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Podoconiosis</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus <xref ref-type="bibr" rid="article-19509.r26">[26]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19509.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although treatable, there are many cases refractory to treatment; therefore, early intervention with regular follow-up is essential to reduce morbidity and mortality. Because there is rare internal organ involvement and the disease remains mostly cutaneous, there is less likely to be mortality due to the disease, except in certain cases, such as those with disseminated disease.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;Without treatment, complications are likely to occur, and with treatment, monitoring must be performed to observe patients for adverse effects of treatment (eg, hepatotoxicity).</p>
      </sec>
      <sec id="article-19509.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most common&#x000a0;complications&#x000a0;of chromoblastomycosis&#x000a0;include scarring (especially atrophic scarring), disabling tissue fibrosis (which could lead to ectropion or joint immobility), ulceration, secondary bacterial infection, lymphatic spread in a sporotrichoid pattern, and lymphedema&#x000a0;resulting in elephantiasis.<xref ref-type="bibr" rid="article-19509.r9">[9]</xref><xref ref-type="bibr" rid="article-19509.r26">[26]</xref> There have been rare, documented cases of malignant transformation of&#x000a0;chromoblastomycosis to squamous cell carcinoma and other rare cases of disseminated diseases, though this is unlikely as compared with other dematiaceous fungi.<xref ref-type="bibr" rid="article-19509.r95">[95]</xref><xref ref-type="bibr" rid="article-19509.r96">[96]</xref><xref ref-type="bibr" rid="article-19509.r97">[97]</xref></p>
      </sec>
      <sec id="article-19509.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive significant education on the prevention&#x000a0;of chromoblastomycosis. Avoidance of cutaneous trauma in endemic areas is essential, and wearing protective equipment is important if individuals work&#x000a0;outdoors or are engaged in outdoor recreation.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;However, many patients susceptible to chromoblastomycosis live in low-resource settings with high temperatures, so reasonable planning should be discussed with patients who are manageable. Vaccination studies are limited, and no commercial vaccine exists for chromoblastomycosis.<xref ref-type="bibr" rid="article-19509.r26">[26]</xref>&#x000a0;During treatment, patients should&#x000a0;be educated on the expected treatment course ( which may be lengthy with multiple treatments) to ensure patient compliance with treatment. Discussion on the myriad adverse effects of treatment medications should be discussed thoroughly, and any drug-drug interactions should be discussed.</p>
      </sec>
      <sec id="article-19509.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chromoblastomycosis is a rare fungal infection and is best managed by an interprofessional team that includes an infectious disease consultant, surgeon, emergency department physician, wound care nurse, dermatologist, and an internist. Chromoblastomycosis is a chronic granulomatous infection of the skin and subcutaneous tissue caused by several different dematiaceous fungi (brown pigment-producing), resulting in the formation of slow-growing, warty plaques, cauliflower-like lesions that may ulcerate.<xref ref-type="bibr" rid="article-19509.r98">[98]</xref><xref ref-type="bibr" rid="article-19509.r99">[99]</xref><xref ref-type="bibr" rid="article-19509.r100">[100]</xref></p>
        <p>The prognosis depends on lesion size and extent. The clinician can excise single small lesions followed by antifungal therapy. Oral antifungal agents alone are an alternative approach if surgery is not feasible or if the disease is advanced.<xref ref-type="bibr" rid="article-19509.r27">[27]</xref><xref ref-type="bibr" rid="article-19509.r101">[101]</xref></p>
      </sec>
      <sec id="article-19509.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19509&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19509">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/chromoblastomycosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19509">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19509/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19509">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19509.s16">
        <fig id="article-19509.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Chromoblastomycosis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chromoblastomycosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19509.s17">
        <fig id="article-19509.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Chromomycosis of Skin Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chromomycosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19509.s18">
        <title>References</title>
        <ref id="article-19509.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartsough</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Martinez-Lage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Branda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sohani</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Zukerberg</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Dematiaceous fungal infections: clinical and pathologic conundrums.</article-title>
            <source>J Clin Pathol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>18</day>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>352</fpage>
            <page-range>352-357</page-range>
            <pub-id pub-id-type="pmid">38272660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenoy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Girisha</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Krishna</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis: A Case Series and Literature Review.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2023</year>
            <season>Sep-Oct</season>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>665</fpage>
            <page-range>665-669</page-range>
            <pub-id pub-id-type="pmid">37727562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Linton</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Fungal Infections of Implantation: More Than Five Years of Cases of Subcutaneous Fungal Infections Seen at the UK Mycology Reference Laboratory.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2022</year>
            <month>Mar</month>
            <day>25</day>
            <volume>8</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35448574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zia-Ur-Rehman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Rare Case of Chromoblastomycosis in a 12-year-old boy.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>69</volume>
            <issue>9</issue>
            <fpage>1390</fpage>
            <page-range>1390-1393</page-range>
            <pub-id pub-id-type="pmid">31511733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mugleston</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Usatine</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Wide Morphologic Variability of Chromoblastomycosis in the Western Hemisphere.</article-title>
            <source>Skinmed</source>
            <year>2016</year>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>423</fpage>
            <page-range>423-427</page-range>
            <pub-id pub-id-type="pmid">28031127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enbiale</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bekele</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manaye</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Seife</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kebede</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gebremeskel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>van Griensven</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Subcutaneous mycoses: Endemic but neglected among the Neglected Tropical Diseases in Ethiopia.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>e0011363</fpage>
            <pub-id pub-id-type="pmid">37756346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garzon</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Rueda</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Celis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cardenas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guevara-Suarez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title><italic>Exophiala psychrophila</italic>: A new agent of chromoblastomycosis.</article-title>
            <source>Med Mycol Case Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>23</volume>
            <fpage>31</fpage>
            <page-range>31-33</page-range>
            <pub-id pub-id-type="pmid">30533349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torres</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beristain</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Lievanos</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis associated with a lethal squamous cell carcinoma.</article-title>
            <source>An Bras Dermatol</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-70</page-range>
            <pub-id pub-id-type="pmid">20520950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rios</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Paiva</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Paula</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Arantes</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Limongi</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Chromomycosis, an unusual cause of cicatricial ectropion: a case report.</article-title>
            <source>Arq Bras Oftalmol</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-48</page-range>
            <pub-id pub-id-type="pmid">28380102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potenciano da Silva</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Moraes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lechner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lindner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Almeida Soares</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Silva-Bail&#x000e3;o</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Bail&#x000e3;o</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Fonsecaea pedrosoi produces ferricrocin and can utilize different host iron sources.</article-title>
            <source>Fungal Biol</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>127</volume>
            <issue>12</issue>
            <fpage>1512</fpage>
            <page-range>1512-1523</page-range>
            <pub-id pub-id-type="pmid">38097325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abad&#x000ed;as-Granado</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Mateo</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Stchigel</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis due to Cladophialophora immunda: An emerging pathogen in immunocompromised patients?</article-title>
            <source>Enferm Infecc Microbiol Clin (Engl Ed)</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-53</page-range>
            <pub-id pub-id-type="pmid">36443189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abliz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takizawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis.</article-title>
            <source>FEMS Immunol Med Microbiol</source>
            <year>2004</year>
            <month>Jan</month>
            <day>15</day>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-9</page-range>
            <pub-id pub-id-type="pmid">14734185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voidaleski</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Azevedo</surname>
                <given-names>CMPES</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>BJFS</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Bombassaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fornari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cristina Lopes da Silva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Lustosa</surname>
                <given-names>BPR</given-names>
              </name>
              <name>
                <surname>Najafzadeh</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Environmental Screening of <italic>Fonsecaea</italic> Agents of Chromoblastomycosis Using Rolling Circle Amplification.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2020</year>
            <month>Nov</month>
            <day>17</day>
            <volume>6</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">33212756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudhadham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Menken</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Gerrits van den Ende</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Sihanonth</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Rapid screening for genotypes as possible markers of virulence in the neurotropic black yeast Exophiala dermatitidis using PCR-RFLP.</article-title>
            <source>J Microbiol Methods</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-42</page-range>
            <pub-id pub-id-type="pmid">19961882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Menezes da Silva</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis Caused by <italic>Phialophora</italic>-Proven Cases from Mexico.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2021</year>
            <month>Jan</month>
            <day>29</day>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">33572699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Rojas</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis caused by Rhinocladiella aquaspersa.</article-title>
            <source>Med Mycol Case Rep</source>
            <year>2013</year>
            <month>Aug</month>
            <day>31</day>
            <volume>2</volume>
            <fpage>148</fpage>
            <page-range>148-51</page-range>
            <pub-id pub-id-type="pmid">24432242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim-Granet</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>de Bi&#x000e8;vre</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Study of the conidial development and cleistothecium-like structure of some strains of Fonsecaea pedrosoi. Comparison with other close Dematiaeae.</article-title>
            <source>Mycopathologia</source>
            <year>1984</year>
            <month>Feb</month>
            <day>15</day>
            <volume>84</volume>
            <issue>2-3</issue>
            <fpage>181</fpage>
            <page-range>181-6</page-range>
            <pub-id pub-id-type="pmid">6538933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guevara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nery</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>de Souza Carvalho Melhem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonfietti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hagen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Carvalho</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>de Camargo</surname>
                <given-names>ZP</given-names>
              </name>
              <name>
                <surname>de Souza Lima</surname>
                <given-names>BJF</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.</article-title>
            <source>Mycoses</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>1146</fpage>
            <page-range>1146-1158</page-range>
            <pub-id pub-id-type="pmid">35869803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>57 Suppl 19</volume>
            <issue>Suppl 19</issue>
            <fpage>46</fpage>
            <page-range>46-50</page-range>
            <pub-id pub-id-type="pmid">26465369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guevara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siqueira</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Nery</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Cavalcante</surname>
                <given-names>LRDS</given-names>
              </name>
              <name>
                <surname>Hagen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis in Latin America and the Caribbean: Epidemiology over the past 50 years.</article-title>
            <source>Med Mycol</source>
            <year>2021</year>
            <month>Dec</month>
            <day>08</day>
            <volume>60</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">34637525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Raphael</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thappa</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Subcutaneous Mycoses in Northeast India: A Retrospective Study.</article-title>
            <source>Indian J Dermatol</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>496</fpage>
            <page-range>496-501</page-range>
            <pub-id pub-id-type="pmid">30504979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aayilliath K</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chakrabarti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Burden of Serious Fungal Infections in India.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>ofac603</fpage>
            <pub-id pub-id-type="pmid">36589484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>DWCL</given-names>
              </name>
              <name>
                <surname>de Azevedo</surname>
                <given-names>CMPES</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>The global burden of chromoblastomycosis.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>15</volume>
            <issue>8</issue>
            <fpage>e0009611</fpage>
            <pub-id pub-id-type="pmid">34383752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Salgado</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roilides</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Azevedo</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Pana</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>233</fpage>
            <page-range>233-276</page-range>
            <pub-id pub-id-type="pmid">27856522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez Mart&#x000ed;nez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez Tovar</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis.</article-title>
            <source>Clin Dermatol</source>
            <year>2007</year>
            <season>Mar-Apr</season>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-94</page-range>
            <pub-id pub-id-type="pmid">17350498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passero</surname>
                <given-names>LFD</given-names>
              </name>
              <name>
                <surname>Cavallone</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Belda</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.</article-title>
            <source>J Immunol Res</source>
            <year>2021</year>
            <volume>2021</volume>
            <fpage>9742832</fpage>
            <pub-id pub-id-type="pmid">34761009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brito</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bittencourt</surname>
                <given-names>MJS</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.</article-title>
            <source>An Bras Dermatol</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>495</fpage>
            <page-range>495-506</page-range>
            <pub-id pub-id-type="pmid">30066754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fahal</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Falci</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Caceres</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Chiller</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pasqualotto</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Neglected endemic mycoses.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>e367</fpage>
            <page-range>e367-e377</page-range>
            <pub-id pub-id-type="pmid">28774696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peltroche-Llacsahuanga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schnitzler</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jentsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Platz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Hoog</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schweizer</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Analyses of phagocytosis, evoked oxidative burst, and killing of black yeasts by human neutrophils: a tool for estimating their pathogenicity?</article-title>
            <source>Med Mycol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-14</page-range>
            <pub-id pub-id-type="pmid">12627799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rozental</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages.</article-title>
            <source>Mycopathologia</source>
            <year>1994</year>
            <month>May</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-91</page-range>
            <pub-id pub-id-type="pmid">8065435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kneipp</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Magalh&#x000e3;es</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Abi-Chacra</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Meyer-Fernandes</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Surface phosphatase in Rhinocladiella aquaspersa: biochemical properties and its involvement with adhesion.</article-title>
            <source>Med Mycol</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>570</fpage>
            <page-range>570-8</page-range>
            <pub-id pub-id-type="pmid">22320857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmeira</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Goulart</surname>
                <given-names>FRV</given-names>
              </name>
              <name>
                <surname>Granato</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kneipp</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>ALS</given-names>
              </name>
            </person-group>
            <article-title><italic>Fonsecaea pedrosoi</italic> Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors.</article-title>
            <source>Front Microbiol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1383</fpage>
            <pub-id pub-id-type="pmid">30008700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montoya</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Montesino</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Carri&#x000f3;n-&#x000c1;lvarez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Rojas</surname>
                <given-names>OC</given-names>
              </name>
            </person-group>
            <article-title>A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.</article-title>
            <source>Microb Pathog</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>147</volume>
            <fpage>104367</fpage>
            <pub-id pub-id-type="pmid">32649963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmeira</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Kneipp</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>dos Santos</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells.</article-title>
            <source>Mycopathologia</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>170</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-7</page-range>
            <pub-id pub-id-type="pmid">20195904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siqueira</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>de Castro</surname>
                <given-names>RJA</given-names>
              </name>
              <name>
                <surname>Leonhardt</surname>
                <given-names>LCM</given-names>
              </name>
              <name>
                <surname>Jer&#x000f4;nimo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Raiol</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishibe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tavares</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bocca</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e0005461</fpage>
            <pub-id pub-id-type="pmid">28355277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ricard-Blum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Esterre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grimaud</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Collagen cross-linking by pyridinoline occurs in non-reversible skin fibrosis.</article-title>
            <source>Cell Mol Biol (Noisy-le-grand)</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>723</fpage>
            <page-range>723-7</page-range>
            <pub-id pub-id-type="pmid">8268758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torinuki</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Okohchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takematsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tagami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Activation of the alternative complement pathway by Fonsecaea pedrosoi.</article-title>
            <source>J Invest Dermatol</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>83</volume>
            <issue>4</issue>
            <fpage>308</fpage>
            <page-range>308-10</page-range>
            <pub-id pub-id-type="pmid">6481182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breda</surname>
                <given-names>LCD</given-names>
              </name>
              <name>
                <surname>Breda</surname>
                <given-names>CNS</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>JRF</given-names>
              </name>
              <name>
                <surname>Paulo</surname>
                <given-names>LNM</given-names>
              </name>
              <name>
                <surname>Jannuzzi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Albuquerque</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>C&#x000e2;mara</surname>
                <given-names>NOS</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title><italic>Fonsecaea</italic><italic>pedrosoi</italic> Conidia and Hyphae Activate Neutrophils Distinctly: Requirement of TLR-2 and TLR-4 in Neutrophil Effector Functions.</article-title>
            <source>Front Immunol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>540064</fpage>
            <pub-id pub-id-type="pmid">33193308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bocca</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Brito</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tosta</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.</article-title>
            <source>Mycopathologia</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>161</volume>
            <issue>4</issue>
            <fpage>195</fpage>
            <page-range>195-203</page-range>
            <pub-id pub-id-type="pmid">16552481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages.</article-title>
            <source>Mycopathologia</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>175</volume>
            <issue>5-6</issue>
            <fpage>515</fpage>
            <page-range>515-22</page-range>
            <pub-id pub-id-type="pmid">23054330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayakawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghosn</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>da Gloria Teixeria de Sousa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis.</article-title>
            <source>Scand J Immunol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>382</fpage>
            <page-range>382-7</page-range>
            <pub-id pub-id-type="pmid">16970678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teixeira de Sousa</surname>
                <given-names>Mda G</given-names>
              </name>
              <name>
                <surname>Ghosn</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi.</article-title>
            <source>Scand J Immunol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>595</fpage>
            <page-range>595-600</page-range>
            <pub-id pub-id-type="pmid">17083615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>d'Avila</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Pagliari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease.</article-title>
            <source>Mycopathologia</source>
            <year>2003</year>
            <volume>156</volume>
            <issue>2</issue>
            <fpage>51</fpage>
            <page-range>51-60</page-range>
            <pub-id pub-id-type="pmid">12733624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alves de Lima Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Criado</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kanashiro-Galo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seixas Duarte</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Sotto</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Pagliari</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Langerhans Cells Express IL-17A in the Epidermis of Chromoblastomycosis Lesions.</article-title>
            <source>Biomed Hub</source>
            <year>2017</year>
            <season>May-Aug</season>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">31988913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuneto</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Arce-Gomez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Petzl-Erler</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>HLA-A29 and genetic susceptibility to chromoblastomycosis.</article-title>
            <source>J Med Vet Mycol</source>
            <year>1989</year>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-5</page-range>
            <pub-id pub-id-type="pmid">2778577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naranjo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>M&#x000e1;rquez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gendzekhadze</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Mestre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yegres</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Richard-Yegres</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Navas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Montagnani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogando</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Layrisse</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Human leukocyte antigen class I and MICA haplotypes in a multicase family with Cladophialophora carrionii chromoblastomycosis.</article-title>
            <source>Tissue Antigens</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-92</page-range>
            <pub-id pub-id-type="pmid">17026462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>CARD9 deficiency predisposing chromoblastomycosis: A case report and comparative transcriptome study.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>984093</fpage>
            <pub-id pub-id-type="pmid">36159827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sali</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis of the leg.</article-title>
            <source>Pol J Pathol</source>
            <year>2017</year>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-184</page-range>
            <pub-id pub-id-type="pmid">29025254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gajurel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ahrens</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Medlar bodies of chromoblastomycosis.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>e14047</fpage>
            <pub-id pub-id-type="pmid">36852755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dokic</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Verstovsek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis Presenting as a Solitary Lesion in a Non-endemic Region.</article-title>
            <source>Cureus</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>e49791</fpage>
            <pub-id pub-id-type="pmid">38164315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dupont</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Duong</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Mallet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mamzer-Bruneel</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Thervet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bougnoux</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Unusual presentation of chromoblastomycosis due to Cladophialophora carrionii in a renal and pancreas transplant recipient patient successfully treated with posaconazole and surgical excision.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-3</page-range>
            <pub-id pub-id-type="pmid">20002358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schieffelin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Garcia-Diaz</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Loss</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Staffeld-Coit</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garces</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pankey</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>270</fpage>
            <page-range>270-8</page-range>
            <pub-id pub-id-type="pmid">24628809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimura</surname>
                <given-names>TFE</given-names>
              </name>
              <name>
                <surname>Romera</surname>
                <given-names>LMD</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Fonsecaea pedrosoi Conidia Induces Activation of Dendritic Cells and Increases CD11c<sup>+</sup> Cells in Regional Lymph Nodes During Experimental Chromoblastomycosis.</article-title>
            <source>Mycopathologia</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>185</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-256</page-range>
            <pub-id pub-id-type="pmid">32008205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Combination therapy for an elderly patient with chromoblastomycosis caused by <italic>Fonsecaea monophora</italic>: a case report.</article-title>
            <source>Ann Transl Med</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <pub-id pub-id-type="pmid">35282094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guevara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>de Souza Lima</surname>
                <given-names>BJF</given-names>
              </name>
              <name>
                <surname>Nery</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hagen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis-Leprosy Co-Infection in Central West Brazil. Presentation of Three Cases and Literature Review.</article-title>
            <source>Mycopathologia</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>187</volume>
            <issue>4</issue>
            <fpage>363</fpage>
            <page-range>363-374</page-range>
            <pub-id pub-id-type="pmid">35764905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis by Exophiala jeanselmei associated with squamous cell carcinoma.</article-title>
            <source>J Mycol Med</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>101105</fpage>
            <pub-id pub-id-type="pmid">33422739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mutalik</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Bissonnette</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kalmar</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Unique Oral Presentations of Deep Fungal Infections: A Report of Four Cases.</article-title>
            <source>Head Neck Pathol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>682</fpage>
            <page-range>682-690</page-range>
            <pub-id pub-id-type="pmid">32889592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanzoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rapparini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pagliara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Misciali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Starace</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piraccini</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis, A Neglected Fungal Infection.</article-title>
            <source>Mycopathologia</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>188</volume>
            <issue>6</issue>
            <fpage>1103</fpage>
            <page-range>1103-1105</page-range>
            <pub-id pub-id-type="pmid">37856009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JSTW</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>FGD</given-names>
              </name>
              <name>
                <surname>Enokihara</surname>
                <given-names>MMSES</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Tomimori</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous chromoblastomycosis mimicking melanoma in a renal transplant recipient.</article-title>
            <source>Med Mycol Case Rep</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>38</volume>
            <fpage>41</fpage>
            <page-range>41-43</page-range>
            <pub-id pub-id-type="pmid">36393996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assefa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sinatayehu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sendeku</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dires</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis: delayed diagnosis with extensive cutaneous lesions.</article-title>
            <source>Int J Infect Dis</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>131</volume>
            <fpage>50</fpage>
            <page-range>50-52</page-range>
            <pub-id pub-id-type="pmid">36972782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamza</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Mercado</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Skelton</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.</article-title>
            <source>J Cutan Pathol</source>
            <year>2003</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>340</fpage>
            <page-range>340-3</page-range>
            <pub-id pub-id-type="pmid">12753177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sousa</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Mello</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Granato</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Alviano</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>ALS</given-names>
              </name>
              <name>
                <surname>Kneipp</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Biofilm Formation by Chromoblastomycosis Fungi <italic>Fonsecaea pedrosoi</italic> and <italic>Phialophora verrucosa</italic>: Involvement with Antifungal Resistance.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2022</year>
            <month>Sep</month>
            <day>15</day>
            <volume>8</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">36135688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maubon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garnaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ramarozatovo</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Fahafahantsoa</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Cornet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasamoelina</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Molecular Diagnosis of Two Major Implantation Mycoses: Chromoblastomycosis and Sporotrichosis.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2022</year>
            <month>Apr</month>
            <day>09</day>
            <volume>8</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35448613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borges</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ximenes</surname>
                <given-names>B&#x000c1;S</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>FTG</given-names>
              </name>
              <name>
                <surname>Peres</surname>
                <given-names>GBM</given-names>
              </name>
              <name>
                <surname>Hayasaki</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>LCC</given-names>
              </name>
              <name>
                <surname>Ianhez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Garcia-Zapata</surname>
                <given-names>MTA</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of direct examination and culture as compared to the anatomopathological examination for the diagnosis of chromoblastomycosis: a systematic review.</article-title>
            <source>An Bras Dermatol</source>
            <year>2022</year>
            <season>Jul-Aug</season>
            <volume>97</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-434</page-range>
            <pub-id pub-id-type="pmid">35643736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oberto-Perdig&#x000f3;n</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Blanco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Apitz-Castro</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela].</article-title>
            <source>Rev Iberoam Micol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-43</page-range>
            <pub-id pub-id-type="pmid">15813682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vidal</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>de Castro</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Cavalecate</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lacaz</surname>
                <given-names>Cda S</given-names>
              </name>
            </person-group>
            <article-title>Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2003</year>
            <season>Nov-Dec</season>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>315</fpage>
            <page-range>315-8</page-range>
            <pub-id pub-id-type="pmid">14762630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rolon</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tolaymat</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Sokumbi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bodiford</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The Role of Excision for Treatment of Chromoblastomycosis: A Cutaneous Fungal Infection Frequently Mistaken for Squamous Cell Carcinoma.</article-title>
            <source>Dermatol Surg</source>
            <year>2023</year>
            <month>Jul</month>
            <day>01</day>
            <volume>49</volume>
            <issue>7</issue>
            <fpage>649</fpage>
            <page-range>649-653</page-range>
            <pub-id pub-id-type="pmid">37093678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pavlidakey</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Snow</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Mohs</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis treated by Mohs micrographic surgery.</article-title>
            <source>J Dermatol Surg Oncol</source>
            <year>1986</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>1073</fpage>
            <page-range>1073-5</page-range>
            <pub-id pub-id-type="pmid">3760315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jadad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>[Long-pulsed 1064 nm Nd: YAG laser combined with terbinafine against chromoblastomycosis caused by <italic>Fonsecaea nubica</italic> and the effect of laser therapy in a Wistar rat model].</article-title>
            <source>Nan Fang Yi Ke Da Xue Xue Bao</source>
            <year>2019</year>
            <month>Jun</month>
            <day>30</day>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>712</fpage>
            <page-range>712-717</page-range>
            <pub-id pub-id-type="pmid">31270051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review.</article-title>
            <source>Mycoses</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>64</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-23</page-range>
            <pub-id pub-id-type="pmid">32989774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsianakas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pappai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Basoglu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Metze</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tietz</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Luger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Bonsmann</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chromomycosis--successful CO2 laser vaporization.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1385</fpage>
            <page-range>1385-6</page-range>
            <pub-id pub-id-type="pmid">18331317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Soto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carrasco-Gerard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peniche</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both.</article-title>
            <source>Int J Dermatol</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>542</fpage>
            <page-range>542-7</page-range>
            <pub-id pub-id-type="pmid">9268758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous chromoblastomycosis effectively treated with local heat monotherapy.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-462</page-range>
            <pub-id pub-id-type="pmid">30280420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Restrepo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arango</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Bedout</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chromoblastomycosis with itraconazole.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>1988</year>
            <volume>544</volume>
            <fpage>504</fpage>
            <page-range>504-16</page-range>
            <pub-id pub-id-type="pmid">2850755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Purim</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Fillus</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Bordignon</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Lameira</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Van Cutsem</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cauwenbergh</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.</article-title>
            <source>Int J Dermatol</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>805</fpage>
            <page-range>805-12</page-range>
            <pub-id pub-id-type="pmid">1330949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antonello</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Appel da Silva</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Cambruzzi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kliemann</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>329</fpage>
            <page-range>329-31</page-range>
            <pub-id pub-id-type="pmid">21225217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Combination therapy with antifungal drugs.</article-title>
            <source>Mykosen Suppl</source>
            <year>1988</year>
            <volume>2</volume>
            <fpage>45</fpage>
            <page-range>45-53</page-range>
            <pub-id pub-id-type="pmid">3078023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranawaka</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Amarasinghe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hewage</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis: combined treatment with pulsed itraconazole therapy and liquid nitrogen cryotherapy.</article-title>
            <source>Int J Dermatol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-400</page-range>
            <pub-id pub-id-type="pmid">19335426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DERBES</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>FRIEDMAN</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>KRAFCHUK</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis treated by vibrapuncture injection of amphotericin B.</article-title>
            <source>Arch Dermatol</source>
            <year>1959</year>
            <month>Sep</month>
            <volume>80</volume>
            <fpage>286</fpage>
            <page-range>286-7</page-range>
            <pub-id pub-id-type="pmid">13816006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whiting</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chromoblastomycosis with high local concentrations of amphotericin B.</article-title>
            <source>Br J Dermatol</source>
            <year>1967</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>6</issue>
            <fpage>345</fpage>
            <page-range>345-51</page-range>
            <pub-id pub-id-type="pmid">6027196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esterre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Inzan</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Ramarcel</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Andriantsimahavandy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ratsioharana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pecarrere</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Roig</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study.</article-title>
            <source>Br J Dermatol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>134 Suppl 46</volume>
            <fpage>33</fpage>
            <page-range>33-6; discussion 40</page-range>
            <pub-id pub-id-type="pmid">8763467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sa&#x000fa;l</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paredes-Solis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Araiza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fierro-Arias</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chromoblastomycosis with terbinafine: experience with four cases.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-51</page-range>
            <pub-id pub-id-type="pmid">15897168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Criado</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Careta</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Rivitti</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Belda</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-74</page-range>
            <pub-id pub-id-type="pmid">20666671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.</article-title>
            <source>Med Mycol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>745</fpage>
            <page-range>745-7</page-range>
            <pub-id pub-id-type="pmid">18608889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>da Silva Hellwig</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Heidrich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zanette</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Scroferneker</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review.</article-title>
            <source>J Glob Antimicrob Resist</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>16</volume>
            <fpage>108</fpage>
            <page-range>108-114</page-range>
            <pub-id pub-id-type="pmid">30266638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sacht</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Paula</surname>
                <given-names>LZ</given-names>
              </name>
              <name>
                <surname>Aseka</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Goetz</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Gheller</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Torraca</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Response of chromoblastomycosis to voriconazole.</article-title>
            <source>An Bras Dermatol</source>
            <year>2016</year>
            <season>Sep-Oct</season>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>679</fpage>
            <page-range>679-681</page-range>
            <pub-id pub-id-type="pmid">27828652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Sousa</surname>
                <given-names>Mda G</given-names>
              </name>
              <name>
                <surname>Belda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lota</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Criado</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Benard</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Topical application of imiquimod as a treatment for chromoblastomycosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>1734</fpage>
            <page-range>1734-7</page-range>
            <pub-id pub-id-type="pmid">24633683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Criado</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Passero</surname>
                <given-names>LFD</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.</article-title>
            <source>J Dermatol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-412</page-range>
            <pub-id pub-id-type="pmid">31960479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batbayar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Immunomodulation of Fungal &#x003b2;-Glucan in Host Defense Signaling by Dectin-1.</article-title>
            <source>Biomol Ther (Seoul)</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>433</fpage>
            <page-range>433-45</page-range>
            <pub-id pub-id-type="pmid">24009832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azevedo</surname>
                <given-names>Cde M</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Resende</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>de Sousa</surname>
                <given-names>Mda G</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis.</article-title>
            <source>Mycoses</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-4</page-range>
            <pub-id pub-id-type="pmid">18444974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Criado</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Domingues Passero</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>5</issue>
            <fpage>1852</fpage>
            <page-range>1852-1854</page-range>
            <pub-id pub-id-type="pmid">32815507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heidrich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Koehler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Scroferneker</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2021</year>
            <month>Jul</month>
            <day>16</day>
            <volume>65</volume>
            <issue>8</issue>
            <fpage>e0054621</fpage>
            <pub-id pub-id-type="pmid">33972246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tawade</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gaikwad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deodhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhide</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Romi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Satpute</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Uncommon presentation of chromoblastomycosis.</article-title>
            <source>Cutis</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>101</volume>
            <issue>6</issue>
            <fpage>442;447;448</fpage>
            <pub-id pub-id-type="pmid">30063772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>San-Bias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Urbina</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>March&#x000e1;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Contreras</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Sorais</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>San-Blas</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of Paracoccidioides brasiliensis by ajoene is associated with blockade of phosphatidylcholine biosynthesis.</article-title>
            <source>Microbiology (Reading)</source>
            <year>1997</year>
            <month>May</month>
            <volume>143 ( Pt 5)</volume>
            <fpage>1583</fpage>
            <page-range>1583-1586</page-range>
            <pub-id pub-id-type="pmid">9168609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Marfatia</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Genital elephantiasis as a complication of chromoblastomycosis: A diagnosis overlooked.</article-title>
            <source>Indian J Sex Transm Dis AIDS</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-5</page-range>
            <pub-id pub-id-type="pmid">21938115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Azevedo</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>do Nascimento</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Queiroz-Telles</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Hoog</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Fonsecaea pugnacius, a Novel Agent of Disseminated Chromoblastomycosis.</article-title>
            <source>J Clin Microbiol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>53</volume>
            <issue>8</issue>
            <fpage>2674</fpage>
            <page-range>2674-85</page-range>
            <pub-id pub-id-type="pmid">26085610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queir&#x000f3;z</surname>
                <given-names>AJR</given-names>
              </name>
              <name>
                <surname>Pereira Domingos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ant&#x000f4;nio</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Chromoblastomycosis: clinical experience and review of literature.</article-title>
            <source>Int J Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>11</issue>
            <fpage>1351</fpage>
            <page-range>1351-1355</page-range>
            <pub-id pub-id-type="pmid">30113072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Narang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Chromoblastomycosis: A Prototypal Case.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2019</year>
            <season>Jan/Feb</season>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <pub-id pub-id-type="pmid">30789034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of chromoblastomycosis using ALA-PDT in a patient with leukopenia.</article-title>
            <source>Photodiagnosis Photodyn Ther</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>26</volume>
            <fpage>13</fpage>
            <page-range>13-14</page-range>
            <pub-id pub-id-type="pmid">30769166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rojas-Garc&#x000ed;a</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Carri&#x000f3;n-&#x000c1;lvarez</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Chromoblastomycosis in Mexico. A forgotten disease].</article-title>
            <source>Salud Publica Mex</source>
            <year>2019</year>
            <season>Ene-Feb</season>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">30753765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19509.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.</article-title>
            <source>Mycoses</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-236</page-range>
            <pub-id pub-id-type="pmid">29178398</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
